As the IDH-mutation cannot currently be analyzed non-invasively in the different types of tissue, post-mortem autopsy is the only way to determine the ubiquitous nature (or not) of the IDH-mutation in OD-MS patients. This evidence concerns the gene IDH1 and myeloid sarcoma.